Urology
Volume 64, Issue 2 , Pages 383-388 , August 2004

Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer

  • Stephen Boorjian

      Affiliations

    • Department of Urology, New York Presbyterian Hospital-Weill-Cornell Medical Center, New York, New York, USA
    • ,
  • Stacy Ugras

      Affiliations

    • Department of Urology, New York Presbyterian Hospital-Weill-Cornell Medical Center, New York, New York, USA
    • ,
  • Nigel P Mongan

      Affiliations

    • Department of Pharmacology, New York Presbyterian Hospital-Weill-Cornell Medical Center, New York, New York, USA
    • ,
  • Lorraine J Gudas

      Affiliations

    • Department of Pharmacology, New York Presbyterian Hospital-Weill-Cornell Medical Center, New York, New York, USA
    • ,
  • Xueke You

      Affiliations

    • Department of Urology, New York Presbyterian Hospital-Weill-Cornell Medical Center, New York, New York, USA
    • ,
  • Satish K Tickoo

      Affiliations

    • Department of Pathology, New York Presbyterian Hospital-Weill-Cornell Medical Center, New York, New York, USA
    • ,
  • Douglas S Scherr

      Affiliations

    • Department of Urology, New York Presbyterian Hospital-Weill-Cornell Medical Center, New York, New York, USA
    • Corresponding Author InformationReprint requests: Douglas S. Scherr, M.D., Brady Urology Health Center, 525 East 68th Street, Starr 900, New York, NY 10021, USA

Received 30 December 2003 ,Accepted 11 March 2004.

References 

  1. Jemal A, Murray T, Samuels A, et al.  Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5–26
  2. Hartge P, Harvey EB, Linehan WM, et al.  Unexplained excess risk of bladder cancer in men. J Natl Cancer Inst. 1990;82:1636–1640
  3. Boorman GA. Animal model of human disease (carcinoma of the ureter and urinary bladder). Am J Pathol. 1977;88:251–254
  4. Okajima E, Hiramatsu T, Iriya K, et al.  Effects of sex hormones on development of urinary bladder tumours in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Urol Res. 1975;3:73–79
  5. Imada S, Akaza H, Ami Y, et al.  Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats. Eur Urol. 1997;31:360–364
  6. Brinkmann AO, Faber PW, van Rooij HC, et al.  The human androgen receptor (domain structure, genomic organization and regulation of expression). J Steroid Biochem. 1989;34:307–310
  7. Ruizeveld de Winter JA, Trapman J, Vermey M, et al.  Androgen receptor expression in human tissues (an immunohistochemical study). J Histochem Cytochem. 1991;39:927–936
  8. Wilson CM, McPhaul MJ. A and B forms of the androgen receptor are expressed in a variety of human tissues. Mol Cell Endocrinol. 1996;120:51–57
  9. Kimura N, Mizokami A, Oonuma T, et al.  Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. J Histochem Cytochem. 1993;41:671–678
  10. Celayir S, Ilce Z, Dervisoglu S. The sex hormone receptors in the bladder in childhood—I (preliminary report in male subjects). Eur J Pediatr Surg. 2002;12:312–317
  11. Laor E, Schiffman ZJ, Braunstein JD, et al.  Androgen receptors in bladder tumors. Urology. 1985;25:161–163
  12. Noronha RF, Rao BR. Sex hormone receptors in localized and advanced transitional cell carcinoma of urinary tract in humans. Urology. 1986;28:401–403
  13. Kirkali Z, Cowan S, Leake RE. Androgen receptors in transitional cell carcinoma. Int Urol Nephrol. 1990;22:231–234
  14. Zhuang YH, Blauer M, Tammela T, et al.  Immunodetection of androgen receptor in human urinary bladder cancer. Histopathology. 1997;30:556–562
  15. International Union Against Cancer (UICC) . Urinary bladder. In:  Sobin LH,  Wittekind C editor. TNM: Classification of Malignant Tumors. New York: Wiley-Liss; 1997;p. 187–190
  16. Epstein JI, Amin MB, Reuter VR, et al.  Bladder Consensus Conference Committee   The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol. 1998;22:1435–1448
  17. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques (a comparison between ABC and unlabeled antibody (PAP) procedures). J Histochem Cytochem. 1981;29:577–580
  18. Culig Z, Klocker H, Bartsch G, et al.  Androgen receptors in prostate cancer. J Urol. 2003;170:1363–1369
  19. Hobisch A, Culig Z, Radmayr C, et al.  Distant metastases from prostatic carcinoma express androgen receptor protein. Cancer Res. 1995;55:3068–3072
  20. Moore KL, Persaud TVN. The Developing Human. In: Philadelphia: WB Saunders; 1993;p. 276–289
  21. Sadi MV, Walsh PC, Barrack ER. Immunohistochemical study of androgen receptors in metastatic prostate cancer (comparison of receptor content and response to hormonal therapy). Cancer. 1991;67:3057–3064
  22. Duggan BJ, Gray SB, McKnight JJ, et al.  Oligoclonality in bladder cancer (the implication for molecular therapies). J Urol. 2004;171:419–425
  23. Chen F, Langenstroer P, Zhang G, et al.  Androgen dependent regulation of bacillus Calmette-Guérin induced interleukin-6 expression in human transitional carcinoma cell lines. J Urol. 2003;170:2009–2013

PII: S0090-4295(04)00342-5

doi: 10.1016/j.urology.2004.03.025

Urology
Volume 64, Issue 2 , Pages 383-388 , August 2004

Article Tools

* Image Usage & Resolution